FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Vidacare Gains Clearance for Biopsy System

[ Price : $8.95]

Vidacare receives 510(k) clearance for the OnControl Bone Marrow Biopsy System.

FDA Panel Backs Huntingtons Disease Drug

[ Price : $8.95]

An FDA advisory committee unanimously votes to recommend approval of Prestwick Pharmaceuticals tetrabenazine, indicated for treati...

Orphan Drug Status for Celldexs Brain Cancer Drug

[ Price : $8.95]

FDA grants orphan drug status to Celldex Therapeutics CDX-110, indicated for treating EGFRvIII-expressing brain cancer.

Advisors Look at Atrial Fibrillation Products

[ Price : $8.95]

FDAs Cardio-Renal Advisory Committee will consider recommendations for two drugs to treat atrial fibrillation.

Amgen, FDA Updating ESA Labels

[ Price : $8.95]

FDA and Amgen discuss safety labeling changes for ESAs based on new study results.

Europeans Say Our DTC Regulation Has Failed

[ Price : $8.95]

Four European health groups urge strict control of DTC advertising there, saying U.S. regulation has failed.

Felicity Huffman in AZ Cancer Program

[ Price : $8.95]

AstraZeneca funds a program for breast cancer survivors with actress Felicity Huffman.

FDA Sees Big MD Prescribing Changes Coming

[ Price : $8.95]

FDA deputy commissioner for policy Randy Lutter predicts significant changes in physician prescribing patterns.

Group Wants Gestiva Off Orphan Drug List

[ Price : $8.95]

Sidelines National Support Network asks FDA to revoke orphan drug designation for Adeza Biomedicals Gestiva.

FDA Issues Regs to Index Unapproved Animal Drugs

[ Price : $8.95]

Federal Register Final rule: FDA issues regulations to index legally marketed unapproved new animal drugs for minor species.